Good morning, ladies and gentlemen and welcome to the Cooper-Standard Third Quarter 2020 Earnings Conference Call. During the presentation, all participants will be in listen-only mode. Following the company’s prepared comments we will conduct a question-and-answer session. As a reminder, this conference call is being recorded and the webcast will be available on the Cooper-Standard website for replay later today. I would now like to turn the call over to Roger Hendriksen, Director of Investor Relations.

Thanks, Louise and good morning everyone. We appreciate your spending some time with us today. The members of our leadership team who will be speaking with you on the call this morning are Jeff Edwards, Chairman and Chief Executive Officer and Jon Banas, Executive Vice President and Chief Financial Officer. Before we begin, I need to remind you that this presentation contains forward-looking statements. While they are made based on current factual information and certain assumptions and plans that management currently believes to be reasonable, these statements do involve risks and uncertainties. For more information on forward-looking statements, we ask that you refer to Slide 3 of this presentation and the company’s statements included in periodic filings with the Securities and Exchange Commission. This presentation also contains non-GAAP financial measures. Reconciliations of the non-GAAP financial measures to their most directly comparable GAAP measures are included in the appendix to this presentation. With those formalities out of the way, I'd like to turn the call over to Jeff Edwards.

Thanks, Roger and good morning, everyone. We certainly appreciate this opportunity to review our third quarter results and provide an update on the current status of our operations. We are pleased with the quick recovery of automotive production in the third quarter following a very challenging first half. Our facilities around the world are adapting well to recently implemented safety protocols, and they're certainly working hard to keep up with solid customer demand. As volumes have ramped up, we have remained focused on delivering value for our customers and continuing execution of our margin enhancement plan. Our team has done a terrific job, and our results for the quarter reflect that. On Slide 5 we provide some highlights from the quarter's performance. Our operations performance was strong during the third quarter. We continue to deliver world-class results for product quality, customer service, and employee safety. At the end of the quarter, 96% of our customer scorecards for product quality were green and 98% were green for launch. Most importantly, the safety performance of our plants continues to be outstanding. Through the first nine months of the year, our total safety incident rate was just 0.36 per 100,000 hours worked, and 32 of our plants still have a perfect record of zero reported incidents. Our plant managers and their teams are doing a world-class job. From a financial perspective, our plan to improve margins and return on invested capital are gaining traction. During the third quarter, we were able to deliver $10 million in cost savings through lean initiatives and improving operating efficiencies. Through the first nine months of the year, manufacturing cost savings totaled $47 million. The aggressive actions we implemented to reduce administrative and overhead costs in 2019 and early this year resulted in a $12 million reduction in SGA&E expense for the quarter versus the third quarter last year. Our global Supply Chain Optimization initiative is delivering as expected, improving results with $14 million in savings during the third quarter. Combined, these initiatives were a significant factor in achieving a 210 basis point improvement in our third quarter adjusted EBITDA margin. Moving to Slide 6. On this slide we summarize the status of our operations by region. Beginning with Asia-Pacific, I want to give a strong shout-out to the team for achieving a perfect zero incident safety performance in the third quarter. Additionally, 10 of 14 manufacturing facilities had zero reported incidents year-to-date. This is a clear indication of what is possible with our total safety culture and a full-time focus on safety as a top priority for the entire team. Light vehicle production in Asia continues to rebound following the slow start to the year. During the third quarter, our sales outpaced market growth and current customer orders are tracking ahead of our original plan levels. Strong volume combined with continuing success in our cost reduction initiatives helped us drive a strong turnaround in the third quarter and adjusted EBITDA margin for the region. IHS is forecasting an increase in light vehicle production in Q4 versus Q3, and we will look to leverage this strong production with ongoing lean initiatives and overall improvements in operating efficiencies. In Europe, we have seven plants that have maintained perfect safety performance through the first nine months of the year. Safety performance overall for the region remains very strong with total incident rate at better than world-class levels. Light vehicle production in the region has ramped up significantly following shutdowns that impacted Q2 but remained below last year's level in Q3. Excluding the impact of the business we divested at the beginning of the quarter, our sales outpaced regional light vehicle production in the third quarter. Current customer orders are tracking ahead of our original plan levels and our total manufacturing efficiencies are ahead of plan year-to-date. The most recent forecast from IHS anticipates a sequential increase in light vehicle production in Q4 versus Q3, but a slight decline year-over-year. Finally, in the Americas, 15 plants in the region have maintained a perfect safety record through the first three quarters of the year and an overall total incident rate that is better than world-class. Third quarter light vehicle production in North America was up slightly year-over-year. Our sales declined slightly as a result of delayed launches and model year changeovers on certain key platforms. With the continuing success of our cost reduction initiatives, we were able to increase adjusted EBITDA margin in the North American region despite the lower sales volume. Production levels in Brazil remained weak in Q3 as the COVID-19 pandemic continues to weigh on the overall market there. The most recent IHS outlook for North America anticipates a sequential decline of approximately 200,000 units of production in Q4. This is roughly in line with production levels in Q4 of 2019. Our current customer orders remain a bit below our original plan levels. The consolidated company prevention and mitigation of COVID-19 remains a top priority. The added health and safety measures in our facilities appear to have been largely successful, and we're working to offset the related impacts on costs and productivity. Certain government assistance programs, which vary from country to country, have helped in this regard. Moving to slide 7. Our teams have maintained constant focus on the execution of our long-term strategic initiatives throughout the year. Key areas of focus include optimizing our global footprint and reducing fixed overhead costs. We are pleased with the progress we have made so far, and we are beginning to see the positive impact in our results. Since 2019, we have closed or exited 22 facilities. We are currently in the process of closing or consolidating three more before the end of the year. We believe we are on track to deliver in excess of $50 million of annualized fixed cost savings in SGA&E and COGS as compared to 2019. While we have made good progress, we continue to identify additional opportunities to further streamline our operations and improve our overall cost structure. We will provide additional details as these plans are finalized. Turning to slide 8. The execution of our Innovation and Diversification Strategy remains a top priority. In fact, we've intensified our focus on this strategy by bringing two new directors onto our Board with strong experience and knowledge in material science and related industries. To further leverage our expertise, we have formed a Board subcommittee that is charged with the oversight of our innovation and diversification efforts. We are excited to have these new directors join us at this important stage in growing our business into other industries. Customer demand in our Industrial and Specialty Group remains very strong with the lone exception being our aviation business. To leverage the strong demand, we are investing in additional capital equipment to modernize and expand our production capabilities and increase our overall capacity. We remain very optimistic about the growth potential of this business over the longer term. In our Applied Materials Science business, we have signed two new additional development agreements. Consistent with the approach we discussed at the beginning of the year, we are intentionally adding fewer new clients and increasing the emphasis on moving existing technology development towards commercialization. The new agreements are with new customers, but they are within the same markets we have focused on in the past. This is also intentional. While our material science, based on our Fortrex chemistry platform, could be applied over a wide range of industries, we believe a concentrated focus will enable us to leverage our knowledge base to speed the development process and ultimately help us capture a broader share of these select markets. We are pleased that the installation of new prototype equipment at our Global Technology Center is nearing completion. When fully operational, we expect this equipment will help accelerate our technology development process and enable us to move rapidly towards commercialization of new materials and technology. Now let me turn the call over to Jon.

Thanks, Jeff and good morning everyone. In the next few slides, I'll provide some detail on our financial results for the third quarter and also comment on our balance sheet, cash flow and liquidity profile. On slide 10, we show a summary of our results for the third quarter with comparisons to the prior year. Let me touch on some of the key figures. Third quarter 2020 sales were $683.2 million, down 7.6% versus the third quarter of 2019. Lost sales related to the recent divestiture of our business in India and certain operations in Europe accounted for most of the decline, while unfavorable volume and mix and customer price reductions also weighed on the quarter's sales. Excluding the impact of the divestiture, total sales were down less than 1%. Adjusted EBITDA in the third quarter was $64.1 million or 9.4% of sales, up from $53.8 million or 7.3% of sales in the third quarter of 2019. The 19% year-over-year improvement in adjusted EBITDA was driven primarily by improved operating efficiency, continuing optimization of our supply chain, and lower SGA&E expense. In addition, we continue to benefit from various government allowances and subsidies, which were put in place during the second quarter to help offset the impacts of the global COVID-19 pandemic. These positive factors were partially offset by unfavorable volume, mix and customer price, typical inflationary pressures, and increased accruals for incentive compensation. On a U.S. GAAP basis, net income for the quarter was $4.4 million compared to a net loss of $4.9 million in the third quarter of 2019. Excluding restructuring expense and other special items, as well as the associated income tax impact of these items, adjusted net income for the third quarter 2020 was $3.6 million or $0.21 per diluted share compared to $3.8 million or $0.22 per diluted share in the third quarter of 2019. Regarding CapEx, our spending in the third quarter was $10.5 million compared to $35.6 million in the same period a year ago. Our teams continue to do a terrific job of limiting or deferring capital spending wherever possible in response to recent industry challenges. We anticipate that lower investment levels will continue through the remainder of the year. Moving to slide 11. The chart on slide 11 walks the significant drivers of the year-over-year changes in our third quarter adjusted EBITDA. Our ongoing efforts in lean manufacturing and operational efficiency drove $10 million in cost savings for the quarter while positive results from our global supply chain optimization efforts contributed another $14 million. We also benefited from $12 million of lower SGA&E expense as a result of the organizational streamlining we proactively implemented last year as well as elimination of all discretionary spending in response to the pandemic. Rounding out the positive factors, ongoing benefits from COVID-19-related government assistance programs and the divestiture of unprofitable operations added a net $4 million and $3 million respectively. Unfavorable volume mix and price adjustments, normal inflationary pressures and accruals for incentive compensation mentioned before, were partial offsets to the improvement in adjusted EBITDA. The unfavorable volume and mix impacts were primarily in North America and Europe, while volume and mix was favorable in Asia-Pacific. Regarding incentive compensation, recall that in the third quarter of 2019, we reversed incentive compensation accruals when it became clear we would not hit our minimum targets for bonus payout. This year, we have continued to accrue for a partial payout. The resulting year-over-year headwind related to higher incentive compensation in Q3 2020 was approximately $22 million. We continue to improve our operating efficiencies, and we are taking real costs out of our business. It's encouraging to see the results of all this hard work now falling through to the bottom line, and we're not done yet. As Jeff mentioned, we are continuing to evaluate opportunities to further optimize our operating footprint and improve our cost structure over time. In the near term, however, as we turn to calendar year 2021, we anticipate the discontinuation of COVID-related assistance programs, gradual increases in discretionary spending, and unfavorable volume and mix could pressure our margin run rate by 100 to 150 basis points versus this most recent quarter. Moving to Slide 12. While we are pleased with the improvements in our margins, free cash flow was definitely a highlight of our third quarter performance. Strong cash provided by operations and continued conservative capital investment combined to drive over $89 million in free cash flow in the quarter. As a result, we ended the third quarter with $463 million of cash on hand. In addition, the availability on our revolving credit facility increased to $150 million as we had predicted, resulting in total liquidity of $613 million as of September 30, 2020. The revolving facility remains undrawn. In light of the considerable uncertainty which persists in the industry and with economic conditions generally, given COVID-19 cases are once again increasing, we continue to monitor our liquidity carefully. Along with detailed forecasting, we are continuing aggressive measures to reduce and/or defer capital expenditures, costs, and discretionary spending wherever we can. We are maintaining our intense focus on working capital management. Among other initiatives, we are working to accelerate both accounts receivable and tooling collections from our customers as well as to bring down inventory levels. Lastly, a few comments on our asset allocation priorities. We issued $250 million of senior secured notes back in May. We took this prudent action to provide a cash cushion that would allow us to maintain sufficient liquidity should the industry shutdowns have extended longer than what was anticipated, or if the industry were to go through a second wave of shutdowns. Our current intent, which remains subject to future market conditions, is to preserve our cash balance as much as possible, generate additional cash over the next two years, and deleverage as soon as markets and contract terms allow. With that, let me turn the call back over to Jeff.

Thanks Jon. To wrap up our discussion this morning, I'd like to provide an update on some additional detail on our ROIC improvement plan and some broad comments on our outlook. This graphic represents the formalized framework we're using to improve our financial performance and ultimately drive improved return on invested capital. Our focus in this important area is a key driver of our improved results for the quarter. This initiative has also become the road map for our longer-term planning process. As we have said, we are on a two to three-year journey to return to double-digit ROIC. Today we've added some additional detail to the graphic providing key targeted metrics from our three-year strategic plan. With the successful execution of our plans, we anticipate improving gross margins to greater than 15% of sales, maintaining SGA&E expense at less than 9% of sales, and improving adjusted EBITDA margins to greater than 10% of sales. The plan also anticipates continued focus on generating cash by carefully managing capital expenditures targeted at less than 5% of sales, while optimizing working capital. Clearly, we cannot guarantee we'll achieve all of these targets within the next three years, but I assure you that our team is working hard to deliver on all aspects of the plan that we control. I have great confidence in our team, and we are all aligned to execute on clearly defined initiatives. In the near term, our industry and the global economy face significant uncertainty that makes forecasting even more difficult than normal. Increasing COVID cases in various states and countries pose the risk of further closures of portions of our economy. Unemployment levels, though improving, remain high. Consumer confidence has been hurt by the pandemic, and I don't think we will know the full geopolitical impacts of our election for some time to come. So given the high level of economic uncertainty, we're not providing formal financial guidance at this time. While we continue to remove real cost from the business, we do not expect margin increases to be perfectly linear. As Jon mentioned earlier, certain COVID-related government programs that are benefiting us today are scheduled to run out at year-end. As always, light vehicle production volume and mix will be an important factor in our business results. We are encouraged by the strong rebound in light vehicle production following the pandemic. Our customer releases are looking strong in the fourth quarter so far. On the other hand, we're also seeing challenges with labor productivity and availability in certain locations simply due to quarantines and other restrictions. Overall, we anticipate finishing the year strong if planned production levels hold. Lastly, I want to thank our global team of employees for their continued hard work and focus on driving strong improvements across our company. I would also like to thank our customers for their continued trust and support. This concludes our prepared comments. We would like to open the call to questions.

Our first question comes from Mike Ward with Benchmark. Please go ahead.

Thanks. Good morning, everyone.

Good morning, Mike.

Jeff, on line 6 when you're saying current customer order levels are approximately 92% of original plan in Europe, is that plan from pre-COVID, or is that recent plan?

That's pre-COVID, Mike.

Okay. Secondly, could you provide a bit more detail on the positive swing we saw in Asia?

Yes, I think the results of China rebounding faster than anybody would have imagined given what was happening at the beginning of this year, I think are certainly number one the market just came back faster than, I think anyone would have predicted. Number two, our teams have continued to, as we've said across the company, really attack it from a cost and a fixed cost point of view. And then finally, our commercial organization has done a really terrific job of getting us paid, frankly.

Okay. On slide 8, I'm trying to understand how the sequence operates. You have two new development contracts related to these material science projects. You signed a development agreement which ideally leads to a licensing agreement and subsequently to commercialization. Is that correct?

That's correct, Mike. It's the same process that we've been talking about now for a couple of years and we're really pleased with the progress on those agreements that we've signed over the last couple of years and we just talked about two additional ones that just keep the pipeline filled up, frankly.

Okay. And then now regarding the two that are currently commercialized, wire and cable and elastomers, is that correct?

We have not said publicly, Mike, what those are, but clearly wire and cable is going to be.

Well, Avient…

is holding...

Avient came out and said it is commercialized, right?

Yes. I'm really talking about the numbers associated with the deal.

Okay.

So we've talked about names, but we haven't put numbers to it which I think was your question, right?

Well I know they're commercial that was going to be my next question. Have we seen any income yet from either the commercialized products, or is there any indication of orders or pending orders that sort of thing?

Yes, we haven't disclosed any of that because as we've said we have so few customers in these spaces that disclosing anything financially kind of discloses your price. So it will be a while before we're able to do that. But safe to say that the amount of revenue and earnings associated with AMS it's going to be a couple of years down the road before we can disclose those things because of just the few clients that we do have that are in that commercialization stage. So stay tuned for more of it as we go forward. But right now we've kept it pretty under wraps.

Okay. And if there were revenues that were generated in 2021, where would that show up like as far as the segment standpoint? Would it show up in that other category, or is it going to be somewhere else?

Yes, Mike, it's Jon. It would show up in that other category. You're right.

Okay. Okay. All right. Thank you very much.

You’re welcome.

Our next question comes from Joseph Farricielli with Cantor Fitzgerald. Your line is now open.

Hi. Thanks for taking the call. Can you give us an idea on some of the expenses that will be coming back into the P&L that maybe were deferred or any catch-up payments that vendors allowed you to defer on during the COVID period?

Yes. This is Jeff. So we, just at a high level related to what we just talked about in our prepared remarks, clearly during the pandemic period here, we have had travel and entertainment virtually on lockdown with few exceptions as it relates to supporting launches. And that's the number that Jon referred to that obviously going forward there'll be some of that that creeps back in. But I want to make one thing clear that we have learned a lot during the lockdown, if you will, in terms of using technology to communicate with our teams around the world that will certainly have a lasting impact on reduced SGA&E expense. But I think it's a bit unrealistic to think it's going to stay at the lowest levels in history. There will be some expense that comes back next year. That's what Jon was referring to, but it will be significantly lower than previous years because we've learned so much about how to conduct and run this business in a virtual mode that we have now implemented many of those things into our business plan for 2021 through 2023 that will have a lasting impact, and that's how we ensure that it will have a lasting impact is because that's how we're managing and facilitizing and staffing the business. And ultimately that's how we're building the budgets going forward.

Okay. Great. Thank you. Does your bank facilities or your first lien documents allow you to buy back any of the sub notes in the open market?

Yes, Joseph, it's Jon here. The agreements do allow us to do that in the open market. And clearly the price looks attractive as they're trading at $68, I think, is the most recent trade that happened. But at this point, we're focused on capital preservation, just given the uncertainty that both Jeff and I have been referring to here. And then plus once we get back in the market, any activity we would take would be driving that price right back up. So, over time that would hit the attractiveness of going and doing there. So at this point in time we're just sitting back and preserving liquidity as we go forward.

Got it. Thanks for the time.

Our next question comes from Brian DiRubbio with Baird. Please go ahead.

Good morning. I would like to focus on Europe for a moment. How close are we to seeing Europe return to a positive EBITDA and possibly even positive free cash flow?

Yes, Brian, this is Jeff. Looking at the bigger picture, we will likely need to get through 2021. However, as we move into 2022, I expect net income to shift back to a positive state.

Okay. As we consider the situation, many investors are concentrating on the cash drains affecting the company. Based on what you're observing today, could Europe still be a cash drain in 2021?

That's correct. We are still in the middle, as I've mentioned earlier here, we're in the middle of identifying additional fixed costs to come out of our business and that's primarily Europe. And we've done a lot already to become smaller and more profitable in Europe with this divestiture that we just did this year. Next year, we'll take a look at our existing footprint and do some things there to remove significant fixed costs that we'll spend for us in 2022 and 2023.

I fully recognize that exiting businesses is a very expensive proposition in Europe. How should we consider the initial costs of potentially shutting down some capacity compared to the payback period for those costs?

Yes, as I mentioned in my prepared remarks, we are in the process of finalizing several things. That would be one of the several things we're in the process of finalizing, and we'll have more information as we get into either the end of the fourth quarter or early in the first quarter regarding all of those initiatives that I referred to in the prepared remarks.

Understood. That's fair. Finally, just as we think about CapEx, it's going to be under 5% you're targeting under 5% going forward. But material amount and I think historically two-thirds of your CapEx spending was related to new customer program launches, which ultimately does get reimbursed through the tooling receivables as title of that equipment transfers to the OEs. So, shouldn't we be thinking about CapEx more on a net basis post the retooling reimbursement? What does that number really look like?

Hey Brian, it's Jon. We actually separate tooling receivables from our capital expenditures. So, when we talk about capital expenditures being under 5% of sales, that refers to the tooling and equipment owned by Cooper-Standard, while the customer-owned tools are listed separately on our balance sheet. You're correct that we do receive reimbursement either in a lump sum or through a piece price over time. The 5% or below figure pertains to the equipment we are using, which allows us to have greater influence over efficiencies and repurposing that equipment. You're seeing this reflected in the recent disciplined decline in our CapEx number.

Okay. Thanks for the clarification. Appreciate it. Thank you.

Sure.

Our next question comes from Mike Cazayoux with KDP Investment Advisors. Please go ahead.

Hi, congratulations on a great quarter. It looks like your EBITDA margins for this quarter of 9.5%, and you said your goal is to get them above 10%. So, you look like you're just about there. But you also said you can't guarantee it over the next three years that you'd reach that. So, I'm just wondering, is this quarter an anomaly in terms of margins, or can we expect it to remain at these levels going forward?

Hey Mike, it's Jon again. In my prepared remarks, I kind of referred to the benefits we're seeing on the governmental programs related to COVID in the absence of spend that Jeff just was giving some color on a few minutes ago. So really that 100 to 150 basis points I referred to would come off that 9.4% run rate in Q4. When you think about the net $4 million positive impact for us in Q3, you can see that on the bridge in the presentation, there's actually $6 million of good news from government grants and various benefits around the world in various countries. So, like we had indicated, we anticipate that running out here at the first of the year. So, really not a go-forward run rate item that you can count on coming back. And then the increase in discretionary spending such as business travel over time creeping back in will add half of that 150 basis point number that I just talked about.

Okay. And on the 13% secured notes they also have a 35% equity claw back, would that be something that you might consider depending on how the stock reacts?

Yes, again, here not in the short term Mike. We're just looking to preserve cash balances just because of the significant uncertainty. And as things stabilize and we get a few quarters behind us here into next year, then we can take a look at some of those type of activities. So, more to come there. As far as other capital structure-type opportunities or allocation options, clearly we are limited by fixed charge coverage ratios under the term loan and those secured notes. So, not really an option at this time until that fixed charge coverage ratio gets back above two.

Mike, this is Jeff Edwards. Let me just add on to the question you were asking about our long-term expectation regarding double-digit EBITDA as a percent of sales. We have said earlier this year we’ve said on this call and we'll continue to say that we have certainly line of sight to achieve the 10%-plus level of performance as we exit 2022. So, that hasn't changed. What we did say is that there's a lot of things in the industry that we don't control. And so we are absolutely committed to that number as we exit 2022 assuming that the industry volume and mix that we've highlighted as important, not just important to us but important to everybody, holds. So, that's probably the reason for the question that you asked based on the words that we used, but it was more related to what we don't control than it was to what we control. Hopefully that helps.

Yes. Thank you.

Our next question comes from Mike Cahill with Crispin Capital. Please go ahead.

Thanks for taking my question. It's been a long time coming but that was really a strong quarter on multiple fronts. So, congratulations to Jeff, Jon, and the team. Given your successful operational improvements and cost-cutting and divestitures, I'm actually struggling to get to a negative EPS number that the analyst consensus has you for 2021. I'm not looking for specific guidance, but I would greatly appreciate a directional indication. Given that you just posted positive earnings in this past quarter in the midst of COVID, I was hoping that maybe you could dispel the 2021 negative EPS number that consensus has and just say that you're hopeful it will be positive. Thank you. Congratulations.

Thanks, Mike. It's Jon here. I can't comment on the consensus models that were created, but we are confident in our recent performance and believe it will continue into next year. You're correct that we won't be providing specific guidance at this time. However, keep in mind that for half of this year, we didn't have the higher interest load that we will face moving forward due to the secured note purchase issuance. This will have an impact on EPS next year. Nonetheless, the stabilization of our business and the returning volumes will definitely benefit us and help maintain our margin perspective going forward. We will provide more information as we conclude the year, and we will issue formal guidance at that point to give further clarity on our activities. But as it stands, we are quite confident.

Thank you. Good luck, guys.

Thanks.

Our next question comes from Josh Taykowski with Credit Suisse. Please go ahead.

Hi, guys. Jeff, Jon congratulations on a really outstanding quarter. Just a couple of questions. And actually one, just piggybacking on one of the first questions you got. I wanted to dig in a little bit on the regional performance in Asia. I guess starting with revenue is it possible to give any more context on what drove the outperformance there relative to the market? If I'm doing my math correctly it looks like 18% up year-over-year excluding the divestiture versus kind of 11% if you just take IHS estimates. So any additional detail you can provide there, or maybe talk about which customers may have performed better than others?

Yes Josh, it's Jon. I can shed a little bit more light there. For us, our customer mix over in China is much more significantly weighted to the Western joint venture OEMs as opposed to the China domestics. And last year 2019 that business was down almost 30% while the market was down 15% to 19% or so. So you've got that mix phenomenon of our customer base. And so this year, you're seeing strong improvements year-over-year in volumes coming out of those Western joint venture OEMs. In particular for us, we saw volume improvements driven by the GM OEM joint ventures on some global programs. So that has certainly helped the mix for us year-over-year and while we had some outsized performance compared to the market overall.

Got it. That's very helpful. Regarding EBITDA, it seems that much of the growth and turnaround came from cost increases. Can you provide any additional insights on that?

As far as the overall magnitude of the cost reductions that we've taken out, Josh is that your question?

It seems that 14.5% of the increase was due to cost increases. So could you elaborate on that?

Yes. Yes, I got the question now. Remember in my prepared remarks, we talked about the bonus variation being about $22 million year-over-year. In the prior year, we actually reversed accruals. So that showed up as income in the quarter to the tune of $10 million whereas this year, we're continuing to accrue and you've got $11 million of expense. So the combined year-over-year impact in that cost reduction or increase column in the 10-Q is showing a $21 million overall variance year-over-year.

Got it. Okay. And then one last question from me. We saw a positive working capital release this quarter. How should we view working capital in the final quarter of the year, considering this year has been somewhat different compared to the typical working capital release in the fourth quarter?

Yes. It's Jon again, Josh. Clearly, strong cash flow in the quarter here in Q3 driven by the improved earnings, the modest CapEx load that we had as well as the working capital changes. The ramp up in sales, you're always going to have an outflow of accounts receivable. But nonetheless, we had better performance in inventory and accounts payable that we pay more slowly than our customers pay us. So that's always a good working capital position to be in, so really some great performance here in Q3. But then Q4, it's typically our strongest cash flow quarter of the year’s seasonality because we're collecting on receivables and the production levels wind down in mid-December. So, given the seasonal inflows we had in Q3, we're expecting Q4 free cash flow to be essentially neutral and then still deliver on that overall positive free cash flow in the second half of the year that we talked about last time.

Got it. Appreciate the color. Thanks, guys and congrats again.

Thanks, Josh.

It appears there are no more questions. I would now like to turn the call back over to Roger Hendriksen.

Alright. Thanks everybody. We appreciate you joining the call this morning and for your continuing interest in Cooper-Standard. If you have further questions that we didn't address on the call or just want to get into a little bit more detail, please feel free to reach out to me directly. We look forward to staying in touch. This concludes our call today. Thanks again.

Ladies and gentlemen, this concludes today's conference call. Thank you for participating. You may now disconnect.